Clinical Trials Directory

Trials / Sponsors / NantBioScience, Inc.

NantBioScience, Inc.

Industry · 6 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingQUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope
Colorectal Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma
Phase 12018-08-10
WithdrawnQUILT-3.014: A Trial of ABI-011 Administered Weekly in Patients With Advanced Solid Tumors or Lymphomas
Neoplastic Disease
Phase 12017-11-13
TerminatedQUILT-3.013: Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanc
Cancer
Phase 12017-03-04
TerminatedGanitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas
Adenocarcinoma of the Pancreas, Locally Advanced, Unresectable
Phase 22012-05-31
CompletedStudy to Evaluate Mechanisms of Acquired Resistance to Panitumumab
Metastatic Colorectal Cancer
Phase 22009-05-05
CompletedPanitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Ho
Colon Cancer, Colorectal Cancer, Gastrointestinal Cancer
Phase 1 / Phase 22008-10-27